Skip to main content
WW logo

WW · Ww International, Inc. · Investor Relations

Track WW — free
$6.97 -1.00 (-12.55%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$69.69M
Shares
10.00M
Volume · Nov 20 474.38K Avg daily vol (3M) 278.22K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-11-17 Weight Watchers Announces Discounted Prepayment Solicitation to Utilize Up to $10 Million to Reduce Term Loan Debt
2026-11-05 Weight Watchers Announces Third Quarter 2026 Results
2026-10-26 Weight Watchers Schedules Third Quarter 2026 Earnings Conference Call
2026-09-29 Weight Watchers and Google Health Enterprise Launch New Collaboration to Enhance Engagement and Outcomes in Weight Health Programs
2026-09-09 Weight Watchers Appoints Stephen Bye as Chief Executive Officer
2026-09-03 Weight Watchers to Participate in Morgan Stanley Annual Global Healthcare Conference
2026-08-05 Weight Watchers Announces Second Quarter 2026 Results
2026-07-23 Weight Watchers Schedules Second Quarter 2026 Earnings Conference Call
2026-07-09 Sam’s Club® and Weight Watchers® Collaborate to Expand Access to Affordable, Holistic Wellness Experiences for Members
2026-07-08 Weight Watchers and FlavCity Announce Collaboration Focused on Strength, Nutrition, and Community
2026-06-30 Weight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program
2026-06-22 Weight Watchers to Support the American Heart Association’s Healthy Living BEYOND Weight Study
2026-06-16 Weight Watchers and CheqUp Expand Partnership To Deliver Holistic Support for Weight Health in the UK
2026-06-04 Weight Watchers to Increase Access to Comprehensive Weight Loss Options for Patients Nationwide through LillyDirect
2026-05-07 Weight Watchers Announces First Quarter 2026 Results
2026-05-01 Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide)
2026-04-27 Weight Watchers Announces Actions to Utilize Up to $40 million to Pay Down Debt
2026-04-23 Weight Watchers Schedules First Quarter 2026 Earnings Conference Call
2026-04-20 Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors
2026-04-09 Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect
2026-04-09 Weight Watchers Announces Board Committee Appointments

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) - WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced the following updates to the composition of its Board of Directors’ standing committees following the appointments of Lisa Gavales and Sue Gove as independent directors: Audit Committee: Gene Davis (Chair), Sue Gove, Carney Hawks and Nikolaj Sjoqvist; Compensation and Benefits Committee: Carney Hawks (Chair), Gene Davis and Lisa Gavales; Nominating and Corporate Governance Committee: Nikolaj Sjoqvist (Chair), Gene Davis and Sue Gove; and Strategy and Finance Committee: Gene Davis (Chair), Lisa Gavales, Carney Hawks, Mike Mason and Nikolaj Sjoqvist. Office of the CEO Update As previously announced, the Board established a Transition Committee to oversee the Office of the CEO, which comprises Felicia DellaFortuna, the Company’s Chief Financial Officer, and Jon Volkmann, the Company’s

2026-04-07 Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors

New, Independent Directors Bring Deep Consumer, Digital and Turnaround Expertise to Support Strategic Transformation NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) - WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced that it has appointed accomplished executives, Lisa Gavales and Sue Gove, as independent members of the Company’s Board of Directors, effective April 7, 2026. Ms. Gavales and Ms. Gove will serve as directors until the Company’s 2026 annual meeting of shareholders and are expected to stand for election at the annual meeting. Following these appointments, the Board consists of six directors, all of whom are independent. Lisa Gavales and Sue Gove are highly regarded consumer brand leaders with distinct expertise that will enhance the Board as Weight Watchers advances its next phase of growth. Ms. Gavales is a consumer and retail executive with a proven track record of building

2026-04-03 Weight Watchers Announces Leadership Transition and Board Updates

Office of the CEO Established to Oversee Business Operations Board Forms Transition Committee and Commences CEO Search NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) - WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced leadership and governance changes, including the establishment of an Office of the CEO and the formation of a new Transition Committee of the Board of Directors (“the Board”). These actions follow Tara Comonte’s departure from the Company, effective March 31, 2026. The Company’s Board of Directors has initiated a comprehensive search for a permanent successor with the support of a leading executive search firm. During the transition period, the Office of the CEO will oversee business operations and execution of the Company’s strategy. The Office of the CEO comprises Felicia DellaFortuna, Chief Financial Officer, and Jon Volkmann, Chief Operations Officer. In addition, the Board is

2026-03-31 Weight Watchers Announces Best in Market Self-Pay Wegovy® Pricing for Med+ Members and the Launch of Preferred Subscription Pricing for Wegovy via NovoCare®

Through expanded collaboration with Novo Nordisk, eligible Med+ members can now save up to $1,200 per year on Wegovy®, increasing affordable access to FDA-approved GLP-1 treatment leveraging Weight Watchers’ integrated care platform NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) - WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced that eligible Weight Watchers Med+ members will have access to subscription pricing for Wegovy® that significantly reduces out-of-pocket costs and is a result of expanded collaboration between Weight Watchers and Novo Nordisk. The new subscription offer gives Weight Watchers Med+ members access to the lowest available self-pay price in the market for doses of Wegovy not otherwise available through limited-time offers, saving cash-pay members up to $1,200 per year. The announcement coincides with Novo Nordisk’s launch of the industry’s first-of-its-kind medication subscription pricing model

2026-03-16 Weight Watchers Announces Fourth Quarter and Full Year 2025 Results

2025 Total Revenue and Adjusted EBITDA 1,2 above high end of previously provided guidance Total End of Period Subscribers of 2.8 million; End of Period Clinical Subscribers of 130 thousand, up 42% year-over-year with continued growth in first quarter 2026 Fourth Quarter Total Revenue of $163 million; Clinical Subscription Revenue of $27 million, up 32% year-over-year Fourth Quarter Net Loss of $6 million; Net Loss Margin of 3.6%; Adjusted EBITDA 1 of $18 million and Adjusted EBITDA Margin 1 of 11.1% Provides First Quarter 2026 End of Period Subscriber Estimates and Full Year 2026 Financial Guidance NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) - WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced its results for the fourth quarter and full year fiscal 2025 ended December 31, 2025 2 in this Earnings Press Release and a Shareholder Letter posted on the Company’s Corporate Website . “Our industry is

Past events

Date Event Type
2026-11-05 Q3 2026 Earnings Conference Call Earnings call
2026-09-15 Morgan Stanley Annual Global Healthcare Conference Conference
2026-08-05 Q2 2026 Earnings Conference Call Earnings call
2026-05-07 Q1 2026 Earnings Conference Call Earnings call
2026-03-16 Q4 and Full Year 2025 Earnings Conference Call Earnings call
2026-01-14 CJS Securities 26th Annual New Ideas for the New Year Event
2025-11-06 Q3 2025 Earnings Conference Call Earnings call
2025-08-11 Q2 2025 Earnings Conference Call Earnings call
2025-05-06 Investor Conference Call Conference
2025-02-27 Q4 and Full Year 2024 Earnings Conference Call Earnings call
2024-11-06 Q3 2024 Earnings Conference Call Earnings call
2024-08-01 Q2 2024 Earnings Conference Call Earnings call

Source: https://corporate.ww.com/

Key facts CIK 105319 CUSIP 98262P200 13F (30d) 103 filings 87 filers Visit website Investor relations